• 1
    Parkin DM, Bray F, Ferlay J, Pisani P. Estimating the world cancer burden: Globocan 2000. Int J Cancer2001; 94: 1536.
  • 2
    Ferlay J, Bray F, Pisani P, Parkin DM. GLOBOCAN 2000: Cancer Incidence, Mortality and Prevalence Worldwide. Lyon: IARC Press, 2001.
  • 3
    El-Serag HB, Davila JA, Petersen NJ, McGlynn KA. The continuing increase in the incidence of hepatocellular carcinoma in the United States: an update. Ann Int Med2003; 139: 81723.
  • 4
    Kim WR, Gores GJ, Benson JT, Therneau TM, Melton LJ. Mortality and hospital utilization for hepatocellular carcinoma in the United States. Gastroenterology2005; 129: 48693.
  • 5
    Greene FL, Page DL, Fleming ID, et al. AJCC Cancer Staging Manual. New York: Springer, 2002.
  • 6
    Anonymous.A new prognostic system for hepatocellular carcinoma: a retrospective study of 435 patients: the Cancer of the Liver Italian Program (CLIP) investigators [see comment]. Hepatology1998; 28: 7515.
  • 7
    Levy I, Sherman M. The Liver Cancer Study Group of the University of Toronto. Staging of hepatocellular carcinoma: assessment of the CLIP, Okuda, and Child–Pugh staging systems in a cohort of 257 patients in Toronto. Gut 2002; 50: 8815.
  • 8
    Ueno S, Tanabe G, Nuruki K, et al. Discrimination value of the new western prognostic system (CLIP score) for hepatocellular carcinoma in 662 Japanese patients. Cancer of the Liver Italian Program. Hepatology 2001; 34: 52934.
  • 9
    Lin C-Y, Kee K-M, Wang J-H, et al. Is the Cancer of the Liver Italian Program system an adequate weighting for survival of hepatocellular carcinoma? Evaluation of intrascore prognostic value among 36 subgroups. Liver Int 2008; 29: 7481.